What HRT does to a man depends entirely on which hormones are involved. For men with low testosterone, hormone replacement therapy (TRT) restores energy, sex drive, and muscle mass by bringing testosterone levels back to a normal range. For individuals assigned male at birth who take estrogen as part of feminizing hormone therapy, the effects are very different: breast development, softer skin, and redistribution of body fat. These are two distinct treatments with opposite goals, and both fall under the umbrella of “HRT.”
Testosterone Replacement Therapy
Most men searching this question have low testosterone, a condition called hypogonadism. Testosterone levels naturally decline with age, but some men drop low enough to experience symptoms like persistent fatigue, low sex drive, difficulty building muscle, irritability, and brain fog. TRT uses gels, injections, or implanted pellets to bring testosterone back into a healthy range.
The goal isn’t to push testosterone abnormally high. It’s to restore what’s missing. When that happens, the downstream effects touch nearly every system in the body, from metabolism and mood to bone density and red blood cell production.
How the Body Responds Over Time
TRT doesn’t work overnight, and different effects kick in on different timelines. In the first one to three weeks, most men notice early shifts in energy, mental clarity, and motivation. These tend to be subtle but noticeable enough that many describe feeling “more like themselves.”
Between weeks three and six, improvements in libido, sleep quality, and overall mood typically emerge. Sexual desire often picks up within the first month, though erection quality and sexual performance can take longer to follow. By months two and three, the physical changes become more apparent: strength and exercise recovery improve, and body composition starts shifting toward more lean mass and less fat. Full physical results, including meaningful changes in muscle and fat distribution, can take six months to a year of consistent treatment.
Effects on Mood and Energy
One of the most studied benefits of TRT is its effect on mood. A large analysis of over 5,200 men with low testosterone found that those receiving TRT experienced modest but statistically significant improvements in both mood and energy compared to placebo, with benefits measurable at 6, 12, and 24 months. These improvements appeared in men with and without significant depressive symptoms at the start of treatment.
That said, TRT isn’t a cure for depression. The same analysis found no significant improvements in cognition or sleep quality compared to placebo. The mood boost is real but modest, more of a lift out of hormonal fog than a replacement for mental health treatment.
Cardiovascular Safety
For years, there was concern that testosterone therapy might increase the risk of heart attacks and strokes. That question has now been answered with strong evidence. The TRAVERSE trial, the largest study of its kind, enrolled over 5,200 men at high cardiovascular risk and followed them for an average of 33 months. Men receiving testosterone had no greater risk of heart attack, stroke, or cardiovascular death than those on placebo.
The Androgen Society reviewed the TRAVERSE results alongside multiple other large trials, smaller randomized studies, observational data, and 19 meta-analyses. Their conclusion: testosterone therapy in men with genuine deficiency is not associated with increased cardiovascular risk. This held true across age groups and risk profiles, including men over 65 and those with diabetes.
One nuance worth noting: the TRAVERSE trial did observe a slightly higher rate of atrial fibrillation (91 cases vs. 63 on placebo) and pulmonary embolism (24 vs. 12). These are uncommon but worth monitoring, particularly in men with existing heart rhythm issues or clotting risk factors.
Red Blood Cell Changes
Testosterone stimulates the production of red blood cells, which is one reason men on TRT often feel more energetic. But this effect can overshoot. When red blood cell concentration (measured as hematocrit) climbs too high, the blood becomes thicker and more viscous, raising the risk of blood clots in both arteries and veins.
Medical guidelines generally flag a hematocrit level above 54% as the threshold for concern. At that point, treatment may need to be paused or the dose adjusted. In the TRAVERSE trial, fewer than 1% of men on testosterone gel exceeded this threshold. However, a separate trial found that 22% of participants hit 54% or higher, with 5% needing to stop treatment entirely. The difference likely comes down to dosing, delivery method, and individual variation.
This is why regular blood work is a standard part of TRT. Hematocrit is checked periodically, and adjustments are made before problems develop.
Fertility and Sperm Production
This is one of the most important and most overlooked effects. When you take testosterone from an outside source, your body reads the incoming hormone as a signal to stop producing its own. That shuts down the chain of hormonal signals that drives sperm production. The result: most men on TRT become functionally infertile while on treatment, and many develop azoospermia, meaning no measurable sperm at all.
As Cleveland Clinic urologist Scott Lundy has noted, many men are never told about this side effect before starting therapy. If you’re considering having children or aren’t sure, this needs to be part of the conversation before beginning TRT. Fertility often recovers after stopping treatment, but it isn’t guaranteed, and recovery can take months to over a year.
Prostate Health
Another longstanding concern was that testosterone therapy might fuel prostate cancer. Current evidence does not support that link. Multiple studies of older men with low testosterone who received TRT found no higher rates of prostate cancer compared to men who didn’t receive treatment. Even among men previously treated for prostate cancer with no signs of recurrence, testosterone therapy doesn’t appear to increase the risk of the cancer returning.
What can happen is a rise in PSA levels, the blood marker used to screen for prostate issues. Higher PSA readings lead to more biopsies, which can detect cancers that might have gone unnoticed otherwise. This is a detection effect, not a causation effect, but it does mean PSA monitoring is part of routine TRT follow-up.
Delivery Methods
TRT comes in several forms, and the choice affects how steadily testosterone levels are maintained. Daily-use options like topical gels and patches keep hormone levels the most consistent because they deliver a small, steady dose every day. Injections, whether given weekly or every few weeks, produce a spike shortly after administration followed by a gradual decline. Implanted pellets follow a similar pattern: a rapid rise within 48 hours, then a slow tapering over months until the next insertion.
For most men, the practical decision comes down to convenience, cost, and tolerance. Gels require daily application and carry a small risk of transferring testosterone to others through skin contact. Injections are less frequent but can cause noticeable highs and lows in energy and mood between doses. Pellets require a minor office procedure every few months but need no daily attention.
Feminizing Hormone Therapy in Male Bodies
When the question “what does HRT do to a man” refers to estrogen-based therapy, the effects are fundamentally different. Feminizing hormone therapy, typically used by transgender women, suppresses testosterone while introducing estrogen. The physical changes are significant and follow a predictable timeline.
Breast development begins within three to six months and reaches its full extent over two to three years. Skin becomes softer and less oily on a similar timeline. Body fat gradually redistributes from the abdomen toward the hips and thighs. Body hair thins and grows more slowly, while muscle mass and strength decrease as testosterone levels fall.
Some of these changes reverse if hormone therapy stops. Others, particularly breast development, are permanent. Sexual function also changes: spontaneous erections decrease or stop, testicular size diminishes, and fertility is significantly impaired, often permanently with long-term use.